CA2633338C - The invention relates to a method of viral inactivation by dry heating - Google Patents

The invention relates to a method of viral inactivation by dry heating Download PDF

Info

Publication number
CA2633338C
CA2633338C CA2633338A CA2633338A CA2633338C CA 2633338 C CA2633338 C CA 2633338C CA 2633338 A CA2633338 A CA 2633338A CA 2633338 A CA2633338 A CA 2633338A CA 2633338 C CA2633338 C CA 2633338C
Authority
CA
Canada
Prior art keywords
biological product
heating
glass transition
viral
dry
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2633338A
Other languages
English (en)
French (fr)
Other versions
CA2633338A1 (en
Inventor
Annie Bardat
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LFB SA
Original Assignee
LFB SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LFB SA filed Critical LFB SA
Publication of CA2633338A1 publication Critical patent/CA2633338A1/en
Application granted granted Critical
Publication of CA2633338C publication Critical patent/CA2633338C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/02—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using physical processes
    • A61L2/04—Heat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2103/00—Materials or objects being the target of disinfection or sterilisation
    • A61L2103/05—Living organisms or biological materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
CA2633338A 2005-12-19 2006-12-19 The invention relates to a method of viral inactivation by dry heating Active CA2633338C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0512875 2005-12-19
FR0512875A FR2894830B1 (fr) 2005-12-19 2005-12-19 Procede d'inactivation virale par chauffage a sec selon la temperature de transition vitreuse
PCT/FR2006/002817 WO2007071845A2 (fr) 2005-12-19 2006-12-19 Procede d'inactivation virale par chauffage a sec selon la temperature de transition vitreuse

Publications (2)

Publication Number Publication Date
CA2633338A1 CA2633338A1 (en) 2007-06-28
CA2633338C true CA2633338C (en) 2012-02-28

Family

ID=36698885

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2633338A Active CA2633338C (en) 2005-12-19 2006-12-19 The invention relates to a method of viral inactivation by dry heating

Country Status (16)

Country Link
US (1) US8252227B2 (https=)
EP (1) EP1981549B1 (https=)
JP (1) JP5085558B2 (https=)
KR (1) KR101162060B1 (https=)
CN (1) CN101355972B (https=)
AT (1) ATE431162T1 (https=)
AU (1) AU2006328804B2 (https=)
BR (1) BRPI0621074B1 (https=)
CA (1) CA2633338C (https=)
DE (1) DE602006006875D1 (https=)
DK (1) DK1981549T3 (https=)
ES (1) ES2327279T3 (https=)
FR (1) FR2894830B1 (https=)
IL (1) IL192194A (https=)
PL (1) PL1981549T3 (https=)
WO (1) WO2007071845A2 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20140093603A (ko) 2010-12-30 2014-07-28 라보라토이레 프란카이즈 듀 프락티온네먼트 에트 데스 바이오테크놀로지스 병원체 불활성화제로서의 글리콜
USD689039S1 (en) * 2012-07-12 2013-09-03 Alljack Co., Ltd. Stereo set
CN109444209A (zh) * 2018-10-26 2019-03-08 北京食品科学研究院 一种测量蛋清粉玻璃化转变温度的方法
CN116059410A (zh) * 2021-08-19 2023-05-05 南京金斯瑞生物科技有限公司 一种去除生物样本中噬菌体的方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2248817C2 (de) * 1972-10-05 1981-09-24 Bayer Ag, 5090 Leverkusen Polycarbonatmischungen
US4456590B2 (en) * 1981-11-02 1989-05-30 Heat treatment of lyphilized blood clotting factor viii concentrate
GB9424732D0 (en) * 1994-12-08 1995-02-08 Common Services Agency Heat treated blood plasma proteins
US5837519A (en) * 1996-11-21 1998-11-17 Bayer Corporation Dry-heat viral inactivation under controlled moisture conditions
AU9775398A (en) * 1997-09-23 1999-04-12 Ib2, L.L.C. Rapid thermal cycle processing methods and apparatus
CN1286725A (zh) * 1997-11-26 2001-03-07 环球保藏技术股份有限公司 敏感性生物样品的玻化保质法
CA2347242C (en) * 1998-10-14 2008-03-25 Katrina T. Forest Method for vitrification of a biological specimen
CA2396219A1 (en) * 2000-01-04 2001-07-12 Xiangzhong Yang Oocyte vitrification technique
EP1651275A1 (en) * 2003-08-05 2006-05-03 Fuji Photo Film B.V. Use of recombinant or synthetic gelatin-like proteins as stabiliser in lyophilized pharmaceutical compositions

Also Published As

Publication number Publication date
FR2894830B1 (fr) 2008-04-04
US20090297398A1 (en) 2009-12-03
JP2009519920A (ja) 2009-05-21
ES2327279T3 (es) 2009-10-27
IL192194A0 (en) 2009-02-11
DK1981549T3 (da) 2009-08-17
BRPI0621074B1 (pt) 2016-07-26
CA2633338A1 (en) 2007-06-28
EP1981549B1 (fr) 2009-05-13
CN101355972B (zh) 2012-07-04
ATE431162T1 (de) 2009-05-15
WO2007071845A3 (fr) 2007-08-16
KR20080093098A (ko) 2008-10-20
EP1981549A2 (fr) 2008-10-22
US8252227B2 (en) 2012-08-28
PL1981549T3 (pl) 2009-10-30
WO2007071845A2 (fr) 2007-06-28
CN101355972A (zh) 2009-01-28
DE602006006875D1 (de) 2009-06-25
AU2006328804A1 (en) 2007-06-28
AU2006328804B2 (en) 2012-08-02
IL192194A (en) 2010-12-30
BRPI0621074A2 (pt) 2011-11-29
FR2894830A1 (fr) 2007-06-22
KR101162060B1 (ko) 2012-07-03
JP5085558B2 (ja) 2012-11-28

Similar Documents

Publication Publication Date Title
JP5719266B2 (ja) ウイルス不活性化熱処理へ供するための血漿タンパク質の寒冷沈降物を安定化する方法
CA1203165A (en) Heat treatment of lyophilized plasma fractions
US5614405A (en) Method of determining the virus inactivation capacity of an inactivation treatment
AU704317B2 (en) Dried blood factor composition comprising trehalose
JPH0739348B2 (ja) 血液生産物中の増殖性を有する▲ろ▼過性病原体の不活性化法および血液生産物の製造方法
JPH0611702B2 (ja) 治療上活性な蛋白質組成物の熱処理方法
IL201146A (en) Process for producing a virus-inactivated thrombin preparation
Lee et al. New methods for inactivation of lipid‐enveloped and nonenveloped viruses
CA2633338C (en) The invention relates to a method of viral inactivation by dry heating
CZ303932B6 (cs) Stabilní hemostaticky aktivní prípravek obsahující von Willebranduv faktor a zpusob jeho prípravy
HU210026B (en) Heparin-free composition for stabilizing blood plasma during pasteurization, and process for pasteurizing blood plasma
JP2879427B2 (ja) ウイルスおよびバクテリア汚染物の熱的不活性化中の生物学的および製薬的生成物の安定化
KR950010321B1 (ko) 인간 트롬빈 제제의 가열처리방법
JP3024073B2 (ja) タンパク質中のウイルスを不活性化する方法
EP1009438A1 (en) Dried biologically or therapeutically active preparations
JPS62289523A (ja) 静脈投与用免疫グロブリンの加熱処理方法
FI96918B (fi) Koostumus veriplasman stabiloimiseksi pastöroinnin aikana
Saleh Nasiri Inactivation OF Poliovirus Type-HSV-IN Human Coagulation Factor VII Concentrate BY Pasteurization
JPS6210019A (ja) 人血液凝固第９因子含有製剤の加熱処理方法
KR960015104B1 (ko) 화학적으로 변형되지 않은 γ-글로부린을 열처리하는 방법
Zandieh et al. THE ROLE OF VARIOUS STABILIZERS IN THE ACQUISITION OF THERMO-TOLER ANCE IN FACTOR VIII ACTIVITY
HU217083B (hu) Vírusinaktivált vérkészítmény
AU8723198A (en) Dried biologically or therapeutically active preparations

Legal Events

Date Code Title Description
EEER Examination request